tiprankstipranks
Trending News
More News >
AstraZeneca (AZN)
NASDAQ:AZN
US Market

AstraZeneca (AZN) Income Statement

Compare
7,507 Followers

AstraZeneca Income Statement

Last quarter (Q3 2025), AstraZeneca's total revenue was $15.19B, an increase of 11.99% from the same quarter last year. In Q3, AstraZeneca's net income was $2.53B. See AstraZeneca’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 54.07B$ 45.81B$ 44.35B$ 37.42B$ 26.62B
Gross Profit
$ 43.87B$ 37.54B$ 31.96B$ 24.98B$ 21.32B
Operating Expenses
$ 33.86B$ 29.35B$ 28.20B$ 23.92B$ 16.16B
Depreciation and Amortization
$ 5.07B$ 4.93B$ 5.25B$ 4.10B$ 2.90B
EBITDA
$ 15.44B$ 13.42B$ 9.09B$ 5.11B$ 8.08B
Operating Income
$ 10.00B$ 8.19B$ 3.76B$ 1.06B$ 5.16B
Other Income/Expenses
$ -1.31B$ -1.29B$ -1.26B$ -1.32B$ -1.25B
Pretax Income
$ 8.69B$ 6.90B$ 2.50B$ -265.00M$ 3.92B
Net Income
$ 7.04B$ 5.96B$ 3.29B$ 112.00M$ 3.20B
Per Share Metrics
Basic EPS
$ 1.14$ 1.91$ 1.06$ 0.04$ 1.22
Diluted EPS
$ 1.13$ 1.91$ 1.06$ 0.04$ 1.22
Weighted Average Shares Outstanding
3.10B 3.12B 3.10B 2.84B 2.62B
Weighted Average Shares Outstanding (Diluted)
3.13B 3.12B 3.12B 2.85B 2.63B
Currency in USD

AstraZeneca Earnings and Revenue History